{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T13:27:07Z","timestamp":1768829227612,"version":"3.49.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s10096-024-04911-x","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T14:03:08Z","timestamp":1722261788000},"page":"2023-2027","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Failure of ceftazidime\/avibactam experimental therapy in the treatment of Klebsiella pneumoniae ST11 co-producing NDM-1 and OXA-48 carbapenemases infection"],"prefix":"10.1007","volume":"43","author":[{"given":"Vajihe Sadat","family":"Nikbin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham Haj Agha","family":"Gholizadeh Khiavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Dehghani-Latani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Hosseinzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Shirzadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samaneh","family":"Pourajam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samereh","family":"Nouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid","family":"Solgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,29]]},"reference":[{"key":"4911_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jgar.2021.04.022","volume":"26","author":"J Gu","year":"2021","unstructured":"Gu J, Xu J, Zuo TT, Chen YB (2021) Ceftazidime-Avibactam in the treatment of infections from carbapenem-resistant Klebsiella pneumoniae: ceftazidime-avibactam against CR-KP infections. J Glob Antimicrob Resist 26:20\u201325","journal-title":"J Glob Antimicrob Resist"},{"issue":"9","key":"4911_CR2","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1093\/cid\/ciab176","volume":"73","author":"M Tumbarello","year":"2021","unstructured":"Tumbarello M, Raffaelli F, Giannella M, Mantengoli E, Mularoni A, Venditti M et al (2021) Ceftazidime-Avibactam Use for Klebsiella pneumoniae carbapenemase-producing K. pneumoniae infections: a Retrospective Observational Multicenter Study. Clin Infect Dis 73(9):1664\u20131676","journal-title":"Clin Infect Dis"},{"issue":"3","key":"4911_CR3","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1093\/jac\/dkaa503","volume":"76","author":"I Karaiskos","year":"2021","unstructured":"Karaiskos I, Daikos GL, Gkoufa A, Adamis G, Stefos A, Symbardi S et al (2021) Ceftazidime\/avibactam in the era of carbapenemase-producing Klebsiella pneumoniae: experience from a national registry study. J Antimicrob Chemother 76(3):775\u2013783","journal-title":"J Antimicrob Chemother"},{"key":"4911_CR4","doi-asserted-by":"crossref","unstructured":"Errico G, Del Grosso M, Pagnotta M, Marra M, Carollo M, Cerquetti M et al (2023) Whole-genome sequencing and molecular analysis of Ceftazidime-Avibactam-resistant KPC-Producing Klebsiella pneumoniae from intestinal colonization in Elderly patients. Antibiot (Basel). ;12(8)","DOI":"10.3390\/antibiotics12081282"},{"issue":"5","key":"4911_CR5","first-page":"609","volume":"15","author":"F Ghanbarinasab","year":"2023","unstructured":"Ghanbarinasab F, Haeili M, Ghanati SN, Moghimi M (2023) High prevalence of OXA-48-like and NDM carbapenemases among carbapenem resistant Klebsiella pneumoniae of clinical origin from Iran. Iran J Microbiol 15(5):609\u2013615","journal-title":"Iran J Microbiol"},{"key":"4911_CR6","doi-asserted-by":"publisher","first-page":"101394","DOI":"10.1016\/j.genrep.2021.101394","volume":"25","author":"N Bolourchi","year":"2021","unstructured":"Bolourchi N, Shahcheraghi F, Giske CG, Nematzadeh S, Solgi H, Badmasti F (2021) Genome analysis of an OXA-48-producing carbapenem- and colistin-resistant Klebsiella pneumoniae sequence type 11 clone isolated from an inpatient. Gene Rep 25:101394","journal-title":"Gene Rep"},{"issue":"1","key":"4911_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12941-021-00479-y","volume":"20","author":"N Bolourchi","year":"2021","unstructured":"Bolourchi N, Shahcheraghi F, Giske CG, Nematzadeh S, Noori Goodarzi N, Solgi H et al (2021) Comparative genome analysis of colistin-resistant OXA-48-producing Klebsiella pneumoniae clinical strains isolated from two Iranian hospitals. Ann Clin Microbiol Antimicrob 20(1):74","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"1","key":"4911_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40545-023-00547-y","volume":"16","author":"S Pourajam","year":"2023","unstructured":"Pourajam S, Zafarbakhsh A, Hosseinzadeh M, Shirzadi M, Siavash M, Solgi H (2023) Secondary bacterial infection caused by ST16 NDM-1 and OXA-48-producing colistin and carbapenem-resistant Klebsiella pneumoniae treated with tigecycline in a pregnant woman with COVID-19. J Pharm Policy Pract 16(1):38","journal-title":"J Pharm Policy Pract"},{"issue":"1","key":"4911_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.diagmicrobio.2010.12.002","volume":"70","author":"L Poirel","year":"2011","unstructured":"Poirel L, Walsh TR, Cuvillier V, Nordmann P (2011) Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis 70(1):119\u2013123","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"4911_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jiph.2017.03.010","volume":"11","author":"MH Al-Agamy","year":"2018","unstructured":"Al-Agamy MH, Aljallal A, Radwan HH, Shibl AM (2018) Characterization of carbapenemases, ESBLs, and plasmid-mediated quinolone determinants in carbapenem-insensitive Escherichia coli and Klebsiella pneumoniae in Riyadh hospitals. J Infect Public Health 11(1):64\u201368","journal-title":"J Infect Public Health"},{"key":"4911_CR11","doi-asserted-by":"crossref","unstructured":"Veeraraghavan B, Bakthavatchalam YD, Sahni RD, Malhotra S, Bansal N, Walia K (2023) Loss of exclusivity of ceftazidime\/avibactam in low- and middle-income countries: a test for antibiotic stewardship practice. Lancet Reg Health - Southeast Asia. ;15","DOI":"10.1016\/j.lansea.2023.100225"},{"issue":"4","key":"4911_CR12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1556\/030.2022.01808","volume":"69","author":"S Shahkolahi","year":"2022","unstructured":"Shahkolahi S, Shakibnia P, Shahbazi S, Sabzi S, Badmasti F, Asadi Karam MR et al (2022) Detection of ESBL and AmpC producing Klebsiella pneumoniae ST11 and ST147 from urinary tract infections in Iran. Acta Microbiol Immunol Hung 69(4):303\u2013313","journal-title":"Acta Microbiol Immunol Hung"},{"key":"4911_CR13","doi-asserted-by":"crossref","unstructured":"Zhan L, Wang S, Guo Y, Jin Y, Duan J, Hao Z et al (2017) Outbreak by Hypermucoviscous Klebsiella pneumoniae ST11 isolates with Carbapenem Resistance in a Tertiary Hospital in China. Front Cell Infect Microbiol. ;7","DOI":"10.3389\/fcimb.2017.00182"},{"key":"4911_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2807\/1560-7917.ES.2023.28.47.2300571","volume":"28","author":"K Tryfinopoulou","year":"2023","unstructured":"Tryfinopoulou K, Linkevicius M, Pappa O, Alm E, Karadimas K, Svartstr\u00f6m O et al (2023) Emergence and persistent spread of carbapenemase-producing Klebsiella pneumoniae high-risk clones in Greek hospitals, 2013 to 2022. Euro Surveill 28:47","journal-title":"Euro Surveill"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-024-04911-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-024-04911-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-024-04911-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T16:22:07Z","timestamp":1726503727000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-024-04911-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,29]]},"references-count":14,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["4911"],"URL":"https:\/\/doi.org\/10.1007\/s10096-024-04911-x","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,29]]},"assertion":[{"value":"22 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethical Committee of the Isfahan University of Medical Sciences (approval number IR.ARI.MUI.REC.1401.300). A waiving of the patient informed consent was approved from the Isfahan University Research ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}